glp-1 risk dvt Carrying excess weight is a known factor for blood clots, but could GLP -1 medications like Ozempic, Wegovy, and Mounjaro help lower that risk? New research suggests they might. Join us for Use of GLP-1 receptor agonists

Theyre great for the right person, said Moore, who is also a professor of clinical practice, medicine and internal medicine at the University of Colorado School of Medicine and researches best practices in patient care through the Brown Moore Endowed Chair for Excellence in Patient Experience

Of these, 185 studies contained overlapping data or appeared in more than one database and were therefore excluded

These effects are typically dose-dependent and often diminish over time with continued use

4.5 Safety profile The safety assessment of GLP-1 receptor agonists indicates a mostly gastrointestinal side effect profile, characterised by dose-dependent symptoms that are often treatable by meticulous titration (Madsbad 2016)